Kingdon Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Kingdon Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-25,000	Closed	-$2.82M	–	161
2015 Q4	$2.82M	Sell	25,000 -75,000	-75%	-$8.26M	0.14%	99
2015 Q3	$11.8M	Sell	100,000 -1,245,700	-93%	-$163M	0.57%	51
2015 Q2	$104M	Buy	1,345,700 +750,400	+126%	+$49.2M	4.07%	3
2015 Q1	$34.4M	Buy	+595,300	New	+$25.3M	1.46%	11

Kingdon Capital Management's ANAC Position: Q3 2016 in Review

Kingdon Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2016, closing a stake of 54,476 shares — an estimated $5.41M sold.

Kingdon Capital Management first reported a position in ANAC in Q2 2013 and held it in 13 quarters. The position peaked at $102M in Q4 2015. 0 funds tracked by Wall St. Rank hold ANAC as of Q3 2016.

Kingdon Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
Kingdon Capital Management sold 54,476 ANACOR PHARMACEUTICALS INC COM shares in Q3 2016, an estimated $5.41M.
Kingdon Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 13 quarters.
Kingdon Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $102M in Q4 2015.
0 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2016.

Based on Kingdon Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.